Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase NA 11Phase 1 9Phase 3 7Phase 1/2 7Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2

Status

Completed 11Unknown 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 55Carcinoma, Hepatocellular 40Neoplasms 38Polycystic Ovary Syndrome 27Colorectal Neoplasms 24Stomach Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Prostatic Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Recurrence 13Pancreatic Neoplasms 13Lymphoma 13Liver Neoplasms 13Urinary Bladder Neoplasms 11Leukemia, Myeloid, Acute 11Esophageal Neoplasms 11Leiomyoma 10Colonic Neoplasms 10Pain 9Lung Neoplasms 9Multiple Myeloma 8Uterine Cervical Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Keratosis, Actinic 7Infertility 7Papillomavirus Infections 6Pain, Postoperative 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

elemene 1aumolertinib 1aflutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Carcinoma × Clear all
NCT04641819 2024-05-31

Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients

ShuGuang Hospital

Phase 4 Unknown
1,127 enrolled

Carcinoma, Sleep Wake Disorders

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Unknown
744 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡